Traditional Chinese Medicinal Capsule for Curing HIV/AID Undergoes Clinical Test
Posted on: Sunday, 31 July 2005, 09:00 CDT
Traditional Chinese medicinal capsule for curing HIV/AID undergoes clinical test
BEIJING, July 30 (Xinhua) -- A traditional Chinese medicinal capsule capable of curing HIV/AIDS has been put under clinical test with the approval of the State Food and Drug Administration.
Chen Dagang, inventor of the capsule and leader in charge of the clinical test, said the clinical test had been carried out in a number of medical establishments in Beijing, including You'an Hospital, the No. 302 Hospital of the Chinese People's Liberation Army, Peking Union Medical College Hospital and Ditan Hospital since July 7, and the test would be completed in nine months.
Pre-stage research in the past five years proves that the capsule, made from 16 kinds of medicinal herbs, is capable of restraining HIV integration enzyme from outside the human body and curbing the virus from duplication inside the infected cell, according to Chen.
Integration enzyme is the third essential element for HIV duplication, or in other words, HIV without integration enzyme is not infectious, said Chen, adding that his capsule, like any other synthetic drugs, had to overcome drug-resistant substance occurring in the process of usage as of the first-generation anti-retrovirus medicine, which might gradually lead to a weakened curing effect.
Source: Xinhua News Agency - CEIS
Related Articles
- Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2
- Roche Diagnostics' HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
- Ichor Medical Systems' TriGrid Selected As Delivery Platform in Collaboration to Test Preventative HIV Vaccine
- Hillcrest Hospital, a Cleveland Clinic Hospital, Unveils Major Campus Expansion Plan
- Amazon Biotech Initiates Negotiations Subsequent to Receiving "Go Ahead" From FDA for Phase I/II HIV Clinical Trial
- Woman Who Allegedly Got HIV in Hospital Dies
- 340B Prime Vendor Program Adds NitroMed, Inc. To Growing List of Companies Providing Low-Cost Drugs to Clinics, Hospitals and Programs for Low-Income Americans
- Thomas Land Publishers Names Leading Scientist Editor-in-Chief of HIV Clinical Trials
- Bangor Clinic Offers OraQuick Test for HIV
- Testing a New HIV Vaccine
 |
 |
User Comments (0)
RSS Feeds